L4W-11981-10311
4 vaccinations
8 coded responses
41 check-ins
7 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 277 / NC
- Registered
- 2021-03-09
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-09
Registered in v-safe
-
2021-03-09
Dose 1 — Moderna
- 2021-03-09
-
2021-03-10
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-03-11
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fever · Headache, Fatigue or tirednessAdult check-in
-
2021-03-12
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fever · Headache, Fatigue or tirednessAdult check-in
- 2021-03-13
- 2021-03-14
-
2021-03-15
Health check-in — days 1–6 daily, dose 1Feeling: Good · Muscle or body aches, NauseaAdult check-in
- 2021-03-16
- 2021-03-23
- 2021-03-30
-
2021-04-06
Dose 2 — Moderna
- 2021-04-06
-
2021-04-07
Survey response — days 1–6 daily, dose 2MedDRA: Sensitive skin — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: Skin sensitive to touchMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Joint pains, Fatigue or tirednessAdult check-in
-
2021-04-09
Survey response — days 1–6 daily, dose 2MedDRA: Abdominal pain, Pregnancy, Vaginal haemorrhage — Feeling: Poor · Site: Pain · Headache, Nausea · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Possible pregnancy miscarriage -- pelvic cramping and heavy vaginal bleedingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-09
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-10
Survey response — days 1–6 daily, dose 2MedDRA: Abortion spontaneous, Pelvic pain, Vaginal haemorrhage — Feeling: Poor · Be unable to work, Be unable to do your normal daily activitiesFree text: Pregnancy miscarriage -- pelvic pain and vaginal bleedingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-11
Survey response — days 1–6 daily, dose 2MedDRA: Abortion spontaneous, Pelvic pain, Vaginal haemorrhage — Feeling: Fair · Fatigue or tirednessFree text: Miscarriage: pelvic pain and vaginal bleedingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-12
Survey response — days 1–6 daily, dose 2MedDRA: Abortion spontaneous — Feeling: FairFree text: MiscarriageMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-13
Survey response — day 7, dose 2MedDRA: Abortion spontaneous — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: MiscarriageMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-20
- 2021-04-27
- 2021-05-04
- 2021-05-11
- 2021-05-12
- 2021-05-18
- 2021-07-06
- 2021-10-05
-
2021-12-15
Dose 3 — Pfizer-BioNTech
- 2022-04-06
- 2022-06-15
-
2022-11-06
Dose 4 — Pfizer-BioNTech
- 2022-11-07
- 2022-11-08
-
2022-11-09
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-11-10
- 2022-11-11
-
2022-11-12
Survey response — days 1–6 daily, dose 4MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
- 2022-11-13
- 2022-11-20
- 2022-11-27
- 2022-12-04
- 2022-12-11
- 2022-12-18
-
2023-02-05
Survey response — 3 months, dose 4MedDRA: Fatigue, Nasal congestion, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-05-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-09 | Moderna | |
| 2 | 2021-04-06 | Moderna | |
| 3 | 2021-12-15 | Pfizer-BioNTech | No |
| 4 | 2022-11-06 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-09 | Unsuccessful |
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Skin sensitive to touch
Systemic reaction (other): Possible pregnancy miscarriage -- pelvic cramping and heavy vaginal bleeding
Systemic reaction (other): Pregnancy miscarriage -- pelvic pain and vaginal bleeding
Systemic reaction (other): Miscarriage: pelvic pain and vaginal bleeding
Systemic reaction (other): Miscarriage
Release 7 — day 7, dose 2
Systemic reaction (other): Miscarriage
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Abdominal pain | ✓ | ✓ | ✓ |
| SRO | Abortion spontaneous | ✓ | ✓ | ✓ |
| SRO | Pelvic pain | ✓ | ✓ | ✓ |
| SRO | Pregnancy | ✓ | ✓ | ✓ |
| SRO | Sensitive skin | ✓ | ✓ | ✓ |
| SRO | Vaginal haemorrhage | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release